Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Morphic Holding Inc (NQ: MORF )

34.01 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 34.01
Bid (Size) 13.61 (2)
Ask (Size) 54.41 (2)
Prev. Close 34.01
Today's Range 34.01 - 34.01
52wk Range 19.34 - 62.08
Shares Outstanding 36,415,045
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Morphic to Participate in Jefferies Global Healthcare Conference
From Morphic Therapeutic
Via GlobeNewswire
Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells
From Morphic Therapeutic
Via GlobeNewswire

Performance

YTD
+17.56%
+17.56%
1 Month
+10.51%
+10.51%
3 Month
-3.38%
-3.38%
6 Month
+14.59%
+14.59%
1 Year
-40.26%
-40.26%

More News

Read More
Morphic to Participate in RBC Capital Markets Global Healthcare Conference
From Morphic Therapeutic
Via GlobeNewswire
Recap: Morphic Holding Q4 Earnings
Via Benzinga
MORF Stock Earnings: Morphic Holding Beats EPS for Q1 2024
Via InvestorPlace
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
From Morphic Therapeutic
Via GlobeNewswire
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc.  (NASDAQ:MORF)
From Abraham, Fruchter & Twersky, LLP
Via GlobeNewswire
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
From Morphic Therapeutic
Via GlobeNewswire
Morphic to Participate in March Investor Conferences
From Morphic Therapeutic
Via GlobeNewswire
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
From Morphic Therapeutic
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Morphic Therapeutic
Via GlobeNewswire
Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors
From Robbins LLP
Via Business Wire
Morphic Holding, Inc. Reminder: Robbins LLP is Investigating MORF on Behalf of Investors
From Robbins LLP
Via Business Wire
Morphic to Present at November Investor Conferences
From Morphic Therapeutic
Via GlobeNewswire
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
From Morphic Therapeutic
Via GlobeNewswire
NASDAQ: MORF Investor Notice: Investigation over Possible Securities Laws Violations by Morphic Holding, Inc.
Via SBWire
Morphic Holding Investigation: Johnson Fistel Encourages Shareholders with Losses to Contact the Firm Regarding Investigation
From Johnson Fistel, LLP
Via Business Wire
Morphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigation
From Johnson Fistel, LLP
Via Business Wire
Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set
From Morphic Therapeutic
Via GlobeNewswire
MORF INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into Morphic Holding, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.